Researchers publish detailed protocol on their new antibody test to be used by researchers and clinicians around the world.
A new AI system can identify optimal combinations of drugs and dosages in a matter of days to help halt viral pandemics before they reach global scales.
Potential vaccine against COVID-19 could begin human trials after FDA approval.
Computational modelling enhances the multidisciplinary approach to understanding the epithelial-to-mesenchymal transition in cancer metastasis.
Researchers have mapped the immune response of one of Australia’s first COVID-19 patients.
Electrospinning is an emerging fabrication technology that holds great promise in advancing skin tissue engineering and in developing an array of novel therapies.
Older individuals in low- and middle-income countries are considered to be the most vulnerable to COVID-19 but have yet to be properly acknowledged in global planning for the disease.
One drug, three modes of action: Clinicians combat the drug resistances of some cancer types by using a combination of different drugs.
A new take on CRISPR allows researchers to “paint” cells and observe never-before-seen cellular processes in great detail.
A new smart bandage is effective in the treatment of chronic wounds brought about by diabetes.
New research published in CANCER indicates that a single dose of the human papillomavirus (HPV) vaccine is as effective as multiple doses for preventing preinvasive cervical disease, which can later develop into cervical cancer.
Although it is essential to develop vaccines for the 2019 coronavirus, it is unlikely that any effort made at the moment will benefit patients in the current outbreak.